LASE Innovation Inc.

LASE Innovation, founded in 2018 and based in Boston, is advancing biomedical research with their patented LP Cell Barcoding™ technology, enabling massively multiplexed barcoding of cells and the unprecedented ability to connect data across multiple single-cell and omics platforms including flow cytometry, imaging and sequencing. LASE Innovation is in the late stages of development of their flagship LASE Cytometer and LP tagging technology enabling Time-lapse flow™ and Multi-pass flow™ cytometry applications that promise to revolutionize how users approach flow cytometry experiments and researchers connect their data across the myriad of platforms leading to accelerated discoveries for health and disease.